SCHEMBL3973859

SCHEMBL3973859

CN(C)NC(O)=S

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29269025 0.91 ALDH1A1 (0.32)
SCHEMBL608811 0.79
Hydrochloric Acid SCHEMBL2406857 0.76
SCHEMBL11596506 0.74 ALDH1A1 (0.44)
SCHEMBL3634614 0.69
SCHEMBL3369217 0.69
SCHEMBL11245909 0.69
SCHEMBL1765501 0.69
SCHEMBL11808418 0.69
SCHEMBL11598592 0.67

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 36 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113527346-A Fluorescent probe based on specific response of BODIPY dye to hypochlorous acid, preparation and application 河南大学 2021-10-22 CN disclosed
EP-1554240-B1 SUBSTITUTED TETRALINS AND INDANES AND THEIR USE JANSSEN PHARMACEUTICA NV (BE) 2009-05-06 EP disclosed
US-7351857-B2 Methods of using substituted tetralins and indanes JANSSEN PHARMACEUTICA N.V. (BE) 2008-04-01 US disclosed
CN-100354259-C Substituted tetralins and indanes and their use JANSSEN PHARMACEUTICA NV (BE) 2007-12-12 CN disclosed
CN-100349864-C Treating syndrome X with substituted tetralins and indanes JANSSEN PHARMACEUTICA NV (BE) 2007-11-21 CN disclosed
EP-1282610-B1 BENZOXAZINE AND BENZOTHIAZINE DERIVATIVES AND THE USE THEREOF IN MEDICAMENTS BAYER SCHERING PHARMA AG (DE) 2007-07-25 EP disclosed
US-20060247314-A1 Substituted tetralins and indanes JANSSEN PHARMACEUTICA N.V. (BE) 2006-11-02 US disclosed
CN-1798732-A Substituted tetralins and indanes JANSSEN PHARMACEUTICA NV (BE) 2006-07-05 CN disclosed
US-20060094786-A1 Treating syndrome X with substituted tetralins and indanes JANSSEN PHARMACEUTICA N.V. (BE) 2006-05-04 US disclosed
US-20060074130-A1 Methods of using substituted tetralins and indanes JANSSEN PHARMACEUTICA N.V. (BE) 2006-04-06 US disclosed
EP-1206458-A1 BENZOXAZINE AND BENZOTHIAZINE DERIVATIVES AND THE USE THEREOF IN MEDICAMENTS Schering Aktiengesellschaft (DE) 2002-05-22 EP disclosed
WO-2001081324-A1 BENZOXAZINE DERIVATIVES AND BENZOTHIAZINE DERIVATIVES HAVING NOS-INHIBITORY AND ANTIOXIDANT PROPERTIES SCHERING AKTIENGESELLSCHAFT (DE) 2001-11-01 WO disclosed
WO-2001081323-A1 BENZOXAZINE AND BENZOTHIAZINE DERIVATIVES AND THE USE THEREOF IN MEDICAMENTS SCHERING AKTIENGESELLSCHAFT (DE) 2001-11-01 WO disclosed
CN-1319097-A Benzoxazine and benzothiazine derivatives and their use in medicines SCHERING AG (DE) 2001-10-24 CN disclosed
EP-1114037-A1 BENZOXAZINE AND BENZOTHIAZINE DERIVATIVES AND THEIR USE IN MEDICINES Schering Aktiengesellschaft (DE) 2001-07-11 EP disclosed
WO-2001014347-A1 BENZOXAZINE AND BENZOTHIAZINE DERIVATIVES AND THE USE THEREOF IN MEDICAMENTS SCHERING AKTIENGESELLSCHAFT (DE) 2001-03-01 WO disclosed
CN-1278802-A Benzoxazine and Benzothiazine derivatives and their use in pharmaceuticals SCHERING AG (DE) 2001-01-03 CN disclosed
EP-1015437-A1 BENZOXAZINE AND BENZOTHIAZINE DERIVATIVES AND THEIR USE IN PHARMACEUTICALS SCHERING AKTIENGESELLSCHAFT (DE) 2000-07-05 EP disclosed
WO-2000017173-A1 BENZOXAZINE AND BENZOTHIAZINE DERIVATIVES AND THEIR USE IN MEDICINES SCHERING AKTIENGESELLSCHAFT (DE) 2000-03-30 WO disclosed
WO-1999012915-A1 BENZOXAZINE AND BENZOTHIAZINE DERIVATIVES AND THEIR USE IN PHARMACEUTICALS SCHERING AKTIENGESELLSCHAFT (DE) 1999-03-18 WO disclosed